Pharvaris N.V. Files Form 4: Ownership Changes Reported
Ticker: PHVS · Form: 4 · Filed: 2026-04-10T13:42:28-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: PHVS
TL;DR
PHVS Form 4 filed - insider ownership changes incoming.
AI Summary
On April 10, 2026, Pharvaris N.V. filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions related to the company's stock, with specific dates and amounts to be detailed within the full document.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a standard disclosure of ownership changes and does not inherently indicate increased risk.
Key Players & Entities
- Pharvaris N.V. (company) — Issuer
- 0001830487 (company) — Pharvaris N.V. CIK
- 2026-04-10 (date) — Filing Date
- 2026-04-09 (date) — Period of Report
- Modig Berndt (person) — Reporting Person
- 0001643072 (person) — Modig Berndt CIK
FAQ
What specific changes in beneficial ownership are reported in this Form 4?
The provided filing details are limited to the form type, filing date, and period of report. Specific transaction details, including the nature of the changes and the number of shares involved, would be found within the full 'ownership.html' or 'ownership.xml' documents.
Who is the reporting person associated with this filing?
The reporting person listed is Modig Berndt, with CIK 0001643072.
When was this Form 4 filing accepted by the SEC?
The Form 4 filing was accepted by the SEC on April 10, 2026, at 13:42:28.
What is the period of report for this ownership change disclosure?
The period of report for this filing is April 9, 2026.
What is the primary business of Pharvaris N.V. according to the filing?
Pharvaris N.V. is classified under SIC code 2834, which pertains to Pharmaceutical Preparations, within the Life Sciences sector.
From the Filing
EDGAR Filing Documents for 0001193125-26-150954 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001193125-26-150954 Filing Date 2026-04-10 Accepted 2026-04-10 13:42:28 Documents 1 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 4 ownership.html 4 1 4 ownership.xml 4 6654 Complete submission text file 0001193125-26-150954.txt 8260 Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018 Business Address Modig Berndt ( Reporting ) CIK : 0001643072 (see all company filings) Type: 4 | Act: 34 | File No.: 001-40010 | Film No.: 26854197 Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410 Pharvaris N.V. ( Issuer ) CIK : 0001830487 (see all company filings) EIN. : 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)